New dyslipidemia guidance from the American Association of Clinical Endocrinology focuses on newer medications and ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.

Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...

Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...

Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Received overwhelming shareholder support in favour of take-private transaction with AditxtAdvanced key pipeline programs, engaged regulatory ...